Integrating kidney transplantation into value-based care for people with renal failure

American Journal of Transplantation

Volumn 18, Issue 1, 2018, Pages 43-52

  Hippen, Benjamin E ^a   Maddux, Franklin W ^b  

^a Metrolina Nephrology Associates   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

business management; dialysis; disparities; economics; ethics and public policy; health services and outcomes research; kidney transplantation nephrology

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; COOPERATION; COST CONTROL; END STAGE RENAL DISEASE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHROLOGY; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLIC POLICY; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; RISK BENEFIT ANALYSIS; RISK FACTOR; VALUE-BASED INSURANCE DESIGN; ECONOMICS; HEMODIALYSIS; INTEGRATED HEALTH CARE SYSTEM; MEDICARE; PROGNOSIS; TRENDS; UNITED STATES;

COST SAVINGS; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; MEDICARE; NEPHROLOGY; PROGNOSIS; QUALITY OF HEALTH CARE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TRANSPLANT RECIPIENTS; UNITED STATES;

EID: 85038845343     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14454     Document Type: Article

References (33)

1. Centers for Medicare & Medicaid Services. (CMS), HHS: medicare program; end-stage renal disease prospective payment system, coverage and payment for renal dialysis services furnished to individuals with acute kidney injury, end-stage renal disease quality incentive program, durable medical equipment, prosthetics, orthotics and supplies competitive bidding program bid surety bonds, state licensure and appeals process for breach of contract actions, durable medical equipment, prosthetics, orthotics and supplies competitive bidding program and fee schedule adjustments, access to care issues for durable medical equipment; and the comprehensive end-stage renal disease care model. Final rule. Fed Regist. 2016;81:77834-77969.
2. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: National Academy Press, 2001
3. Quality payment program. https://qpp.cms.gov/. Accessed May 23, 2017.
4. Comprehensive ESRD Care Model. https://innovation.cms.gov/initiatives/comprehensive-esrd-care/. Accessed May 23, 2017.
5. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11:2093-2109.
6. Matas AJ, Schnitzler M, Daar AS. Payment for living kidney donors (vendors) is not an abstract ethical discussion occurring in a vacuum. Am J Transplant. 2004;4:1380-1381.
7. Held PJ, McCormick F, Ojo A, Roberts JP. A cost-benefit analysis of government compensation of kidney donors. Am J Transplant. 2016;16:877-885.
8. Center for Medicare and Medicaid Innovation Next Generation ACO Model. https://innovation.cms.gov/Files/x/nextgenacorfa.pdf. Accessed May 23, 2017.
9. Schold JD, Buccini LD, Phelan MP, et al. Building an ideal quality metric for ESRD health care delivery. Clin J Am Soc Nephrol. 2017;12:1351-1356.
10. Department of Health and Human Services. Conditions for coverage for end-stage renal disease facilities. Federal Register. Part 494: April 15, 2008. https://www.cms.gov/Regulations-and-Guidance/Legislation/CFCsAndCoPs/downloads/esrdfinalrule0415.pdf.Accessed May 23, 2017.
11. Patzer RE, Sudeshna P, Plantinga L, et al. A randomized trial to reduce disparities in referral for transplant evaluation. J Am Soc Nephrol. 2017;28:935-942.
12. McPherson L, Lipford K, Hamoda R, et al. Perceived patient barriers for kidney transplant evalution among transplant center staff. [abstract]. Am J Transplant. 2017; 17 (suppl 3). http://atcmeetingabstracts.com/abstract/perceived-patient-barriers-for-kidney-transplant-evalution-among-transplant-center-staff/. Accessed May 23, 2017.
13. Garonzik-Wang JM, Berger JC, Ros RL, et al. Live donor champion: finding live kidney donors by separating the advocate from the patient. Transplantation. 2012;93:1147-1150.
14. The community response to viral hepatitis: Contributions toward achieving the goals of the viral hepatitis action plan. 2016. https://www.hhs.gov/sites/default/files/Community_Report%20_FINAL_508_8-11-16.pdf. Accessed May 23, 2017.
15. Waitlist patients: A forgotten group. http://xynmanagement.com/waitlist-patients-forgotten-group/. Accessed May 23, 2017.
16. Shinstock CA, Albright RC, Williams AW, et al. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011;6:1996-2002.
17. Gill JS, Abichandani R, Annamaria TK, et al. Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int. 2002;62:1875-1883.
18. Gill JS, Rose C, Pereira BJG, et al. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int. 2007;71:442-447.
19. Ansell D, Udayaraj UP, Steenkamp R, et al. Chronic renal failure in kidney transplant recipients. Do they receive optimum care? Data from the UK Renal Registry. Am J Transplant. 2007;7:1167-1176.
20. Chan MR, Oza-Gajera B, Chapla K, et al. Initial vascular access type in patients with a failed renal transplant. Clin J Am Soc Nephrol. 2014;9:1225-1231.
21. Garner H, Hippen BE. A late - stage chronic kidney disease tracking tool can successfully increase rates of primary permanent dialysis access utilization in patients with a failing renal allograft. Nephrol News Issues. 2017;31:24-31.
22. Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2015 annual data report: kidney. Am J Transplant. 2017;17(suppl 1):21-116.
23. British Transplantation Society. Management of the failing kidney transplant. 2016. https://bts.org.uk/wp-content/uploads/2016/09/13_BTS_Failing_Graft-1.pdf. Accessed May 23, 2017.
24. Heaphy ELG, Poggio ED, Flechner SM, et al. Risk factors for retransplant kidney recipients: relisting and outcomes from patients’ primary transplant. Am J Transplant. 2014;14:1356-1367.
25. Lacson E, Wang W, DeVries C, et al. Effects of a nationwide predialysis educational program on modality choice, vascular access and patient outcomes. Am J Kidney Dis. 2011;58:235-242.
26. Doyle M, Vachharajani M, Wellen JR, et al. A Novel organ donor facility: a decade of experience with liver donors. Am J Transplant. 2014;14:615-620.
27. Doyle M, Subramanian V, Vachharajani N, et al. Organ donor recovery performed at an organ procurement organization-based facility is an effective way to minimize organ recovery Costs and Increase Organ Yield. J Am Coll Surg. 2016;222:591-600.
28. Engelsbee MJ, Merion RM. The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant. 2009;9:2406-2415.
29. Axelrod DA, Schnitzler MA, Xiao H, et al. The changing financial landscape of renal transplant practice: a national cohort analysis. Am J Transplant. 2017;17:377-389.
30. Axelrod DA. Economic and financial outcomes in transplantation: whose dime is it anyway? Curr Opin Organ Transplant. 2013;18:222-228.
31. OPTN/UNOS: Collaborative Innovation and Improvement Network (COIIN) Cohort B Application and Operational Guidelines. https://optn.transplant.hrsa.gov/media/1889/coiin_application.pdf. Accessed May 23, 2017.
32. Englesbe MJ, Ads Y, Cohn JA, et al. The effects of donor and recipient practices on transplant center finances. Am J Transplant. 2008;8:586-592.
33. Chapter 6: Outpatient dialysis services. In Report to the Congress: Medicare Payment Policy. Medicare Payment Advisory Commission. March 17, 2017. http://www.medpac.gov/docs/default-source/reports/mar17_medpac_ch6.pdf?sfvrsn=0. Accessed June 30, 2017.